Bright Spring Health Services, Inc. BTSG
We take great care to ensure that the data presented and summarized in this overview for BrightSpring Health Services, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BTSG
Top Purchases
Top Sells
About BTSG
Insider Transactions at BTSG
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 25
2024
|
Jon B Rousseau |
SELL
Payment of exercise price or tax liability
|
Direct |
36,740
-3.79%
|
$551,100
$15.5 P/Share
|
Sep 11
2024
|
Walgreens Boots Alliance, Inc. |
SELL
Open market or private sale
|
Indirect |
11,619,998
-33.33%
|
-
|
Sep 11
2024
|
Kkr Group Partnership L.P. |
BUY
Open market or private purchase
|
Indirect |
11,619,998
+11.11%
|
$127,819,978
$11.13 P/Share
|
Sep 11
2024
|
Kkr Phoenix Aggregator L.P. |
BUY
Open market or private purchase
|
Indirect |
11,619,998
+11.11%
|
$127,819,978
$11.13 P/Share
|
Jul 25
2024
|
Jon B Rousseau |
SELL
Payment of exercise price or tax liability
|
Direct |
20,198
-2.04%
|
$242,376
$12.09 P/Share
|
May 20
2024
|
Matthew D Ambrosio |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$11,000
$11.46 P/Share
|
May 10
2024
|
Olivia F Kirtley |
BUY
Grant, award, or other acquisition
|
Direct |
4,449
+18.12%
|
-
|
May 03
2024
|
Olivia F Kirtley |
BUY
Grant, award, or other acquisition
|
Direct |
15,653
+50.0%
|
-
|
May 03
2024
|
Timothy A Wicks |
BUY
Grant, award, or other acquisition
|
Direct |
15,653
+50.0%
|
-
|
Apr 25
2024
|
Jon B Rousseau |
SELL
Payment of exercise price or tax liability
|
Direct |
36,740
-3.58%
|
$367,400
$10.41 P/Share
|
Mar 15
2024
|
Jon B Rousseau |
BUY
Open market or private purchase
|
Indirect |
18,400
+4.74%
|
$147,200
$8.09 P/Share
|
Mar 15
2024
|
Jon B Rousseau |
BUY
Open market or private purchase
|
Direct |
18,400
+1.76%
|
$147,200
$8.09 P/Share
|
Mar 15
2024
|
James F Mattingly Jr |
BUY
Open market or private purchase
|
Direct |
6,080
+4.32%
|
$48,640
$8.26 P/Share
|
Mar 15
2024
|
Jennifer Yowler President, PharMerica |
BUY
Open market or private purchase
|
Direct |
3,000
+4.7%
|
$24,000
$8.21 P/Share
|
Mar 14
2024
|
Jon B Rousseau |
BUY
Open market or private purchase
|
Direct |
37,405
+48.73%
|
$299,240
$8.12 P/Share
|
Mar 14
2024
|
James F Mattingly Jr |
BUY
Open market or private purchase
|
Direct |
12,280
+8.71%
|
$98,240
$8.18 P/Share
|
Mar 14
2024
|
Jennifer A Phipps Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct |
12,300
+6.91%
|
$98,400
$8.14 P/Share
|
Jan 26
2024
|
Jon B Rousseau |
BUY
Grant, award, or other acquisition
|
Direct |
967,884
+49.95%
|
-
|
Jan 26
2024
|
Steven S Reed |
BUY
Grant, award, or other acquisition
|
Direct |
54,658
+36.79%
|
-
|
Jan 26
2024
|
Lisa A Nalley |
BUY
Grant, award, or other acquisition
|
Direct |
96,454
+49.2%
|
-
|
Last 12 Months Summary
Buy / Acquisition
24.9M
Shares
From
17
Insiders
Grant, award, or other acquisition | 1.53M shares |
---|---|
Open market or private purchase | 23.3M shares |
Sell / Disposition
11.7M
Shares
From
2
Insiders
Open market or private sale | 11.6M shares |
---|---|
Payment of exercise price or tax liability | 93.7K shares |